David C. Stump's Insider Trades & SAST Disclosures
David C. Stump's most recent trade in Regenxbio Inc was a trade of 24,454 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on May 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David C. Stump.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Regenxbio Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 24,454 | 24,454 | - | - | Stock Options (Right to Buy) | |
| Regenxbio Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 4,790 | 11,286 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Macrogenics Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 6,500 | 6,500 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | David C. Stump | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 4,500 | 0 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | David C. Stump | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 4,500 | 4,500 (0%) | 0% | 0 | Common Stock | |
| Regenxbio Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 17,892 | 17,892 | - | - | Stock Options (Right to Buy) | |
| Regenxbio Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 3,486 | 6,496 (0%) | 0% | 0 | Common Stock | |
| Regenxbio Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 15,324 | 15,324 | - | - | Stock Option (Right to Buy) | |
| Regenxbio Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 3,010 | 3,010 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Regenxbio Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Macrogenics Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Regenxbio Inc | David C. Stump | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges